Home LiteratureArticle Details
PMID: 1538710 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.

Molecular pharmacology ·Vol. 41 ·No. 2 ·1992-02-00 ·Pages 322-30

Snyders J, Knoth KM, Roberds SL, Tamkun MM

Abstract

The interaction of quinidine with a cloned human cardiac potassium channel (HK2) expressed in a stable mouse L cell line was studied using the whole-cell tight-seal voltage-clamp technique. Quinidine (20 microM) did not affect the initial sigmoidal activation time course of the current. However, it reduced the peak current and induced a subsequent decline, with a time constant of 8.2 +/- 0.8 msec, to 28 +/- 6% of control (at +60 mV). The concentration dependence of HK2 block at +60 mV yielded an apparent KD of 6 microM and a Hill coefficient of 0.9. The degree of block was voltage dependent. Block increased from 0.60 +/- 0.09 at 0 mV to 0.72 +/- 0.06 at +60 mV with 20 microM quinidine and from 0.39 +/- 0.20 to 0.48 +/- 0.16 with 6 microM. Paired analysis in seven experiments with 20 microM quinidine indicated that the voltage-dependent increase in block was significant (difference, 12 +/- 4%; p less than 0.001). This voltage dependence was described by an equivalent electrical distance delta of 0.19 +/- 0.02, which suggested that at the binding site quinidine experienced 19% of the applied transmembrane electrical field, referenced to the inner surface. Quinidine reduced the tail current amplitude and slowed the time course relative to control, resulting in a "crossover" phenomenon. These data indicate that 1) the charged form of quinidine blocks the HK2 channel after it opens, 2) binding occurs within the transmembrane electrical field (probably in or near the ion permeation pathway), and 3) unbinding is required before the channel can close.

MeSH Terms
Amino Acid Sequence Animals Cloning, Molecular Heart/drug effects,physiology Humans Kinetics L Cells Membrane Potentials/drug effects Mice Molecular Sequence Data Myocardium/cytology,ultrastructure Potassium/metabolism,physiology Potassium Channels/drug effects,genetics,physiology Quinidine/pharmacology Receptors, Drug/drug effects,metabolism Tetraethylammonium Tetraethylammonium Compounds/metabolism Time Factors Transfection
Chemicals
Potassium Channels Receptors, Drug Tetraethylammonium Compounds Tetraethylammonium Quinidine Potassium
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Snyders J
Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232-2171.
Knoth K M
Roberds S L
Tamkun M M
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
1992-02-00
Pages
322-30
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NCRR NIH HHS · DRR-2SO7-RR05424 · United States
NIGMS NIH HHS · GM 41325 · United States
NHLBI NIH HHS · HL 40608 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com